Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs4673

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr16:88646828 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
A>G / A>T
Variation Type
SNV Single Nucleotide Variation
Frequency
A=0.342109 (120040/350882, ALFA)
A=0.356980 (94489/264690, TOPMED)
A=0.302295 (75763/250626, GnomAD_exome) (+ 24 more)
A=0.350268 (49020/139950, GnomAD)
A=0.309170 (37344/120788, ExAC)
A=0.34446 (27102/78680, PAGE_STUDY)
A=0.09395 (2654/28250, 14KJPN)
A=0.09187 (1539/16752, 8.3KJPN)
A=0.3412 (2185/6404, 1000G_30x)
A=0.3357 (1681/5008, 1000G)
A=0.2929 (1312/4480, Estonian)
A=0.3324 (1281/3854, ALSPAC)
A=0.3546 (1315/3708, TWINSUK)
A=0.0922 (270/2930, KOREAN)
A=0.2927 (610/2084, HGDP_Stanford)
A=0.3631 (687/1892, HapMap)
A=0.0922 (169/1832, Korea1K)
A=0.329 (328/998, GoNL)
A=0.056 (34/610, Vietnamese)
A=0.247 (148/600, NorthernSweden)
A=0.363 (194/534, MGP)
A=0.196 (98/500, SGDP_PRJ)
A=0.166 (50/302, FINRISK)
A=0.407 (88/216, Qatari)
A=0.43 (38/88, Ancient Sardinia)
A=0.27 (14/52, Siberian)
A=0.23 (9/40, GENOME_DK)
Clinical Significance
Reported in ClinVar
Gene : Consequence
CYBA : Missense Variant
Publications
70 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20231103111315
Population Group Sample Size Ref Allele Alt Allele Ref HMOZ Alt HMOZ HTRZ HWEP
Total Global 366956 A=0.342987 G=0.657013, T=0.000000 0.121873 0.4359 0.442227 34
European Sub 313224 A=0.347231 G=0.652769, T=0.000000 0.122245 0.427783 0.449972 5
African Sub 13428 A=0.45569 G=0.54431, T=0.00000 0.207775 0.296396 0.49583 0
African Others Sub 486 A=0.496 G=0.504, T=0.000 0.251029 0.259259 0.489712 0
African American Sub 12942 A=0.45418 G=0.54582, T=0.00000 0.206151 0.29779 0.496059 0
Asian Sub 6954 A=0.0869 G=0.9131, T=0.0000 0.009203 0.83549 0.155306 1
East Asian Sub 4988 A=0.0874 G=0.9126, T=0.0000 0.006816 0.831997 0.161187 0
Other Asian Sub 1966 A=0.0855 G=0.9145, T=0.0000 0.015259 0.844354 0.140387 6
Latin American 1 Sub 1134 A=0.3686 G=0.6314, T=0.0000 0.137566 0.400353 0.462081 0
Latin American 2 Sub 7212 A=0.2542 G=0.7458, T=0.0000 0.067388 0.559068 0.373544 0
South Asian Sub 5224 A=0.3700 G=0.6300, T=0.0000 0.150459 0.410413 0.439127 5
Other Sub 19780 A=0.31309 G=0.68691, T=0.00000 0.108696 0.482508 0.408797 14


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
Allele Frequency Aggregator Total Global 350882 A=0.342109 G=0.657891, T=0.000000
Allele Frequency Aggregator European Sub 303360 A=0.347989 G=0.652011, T=0.000000
Allele Frequency Aggregator Other Sub 18362 A=0.31266 G=0.68734, T=0.00000
Allele Frequency Aggregator African Sub 8636 A=0.4568 G=0.5432, T=0.0000
Allele Frequency Aggregator Latin American 2 Sub 7212 A=0.2542 G=0.7458, T=0.0000
Allele Frequency Aggregator Asian Sub 6954 A=0.0869 G=0.9131, T=0.0000
Allele Frequency Aggregator South Asian Sub 5224 A=0.3700 G=0.6300, T=0.0000
Allele Frequency Aggregator Latin American 1 Sub 1134 A=0.3686 G=0.6314, T=0.0000
TopMed Global Study-wide 264690 A=0.356980 G=0.643020
gnomAD - Exomes Global Study-wide 250626 A=0.302295 G=0.697705
gnomAD - Exomes European Sub 134694 A=0.307311 G=0.692689
gnomAD - Exomes Asian Sub 48988 A=0.26106 G=0.73894
gnomAD - Exomes American Sub 34568 A=0.22894 G=0.77106
gnomAD - Exomes African Sub 16210 A=0.44904 G=0.55096
gnomAD - Exomes Ashkenazi Jewish Sub 10048 A=0.43232 G=0.56768
gnomAD - Exomes Other Sub 6118 A=0.3341 G=0.6659
gnomAD - Genomes Global Study-wide 139950 A=0.350268 G=0.649732
gnomAD - Genomes European Sub 75822 A=0.31439 G=0.68561
gnomAD - Genomes African Sub 41896 A=0.45412 G=0.54588
gnomAD - Genomes American Sub 13636 A=0.27567 G=0.72433
gnomAD - Genomes Ashkenazi Jewish Sub 3320 A=0.4190 G=0.5810
gnomAD - Genomes East Asian Sub 3122 A=0.0865 G=0.9135
gnomAD - Genomes Other Sub 2154 A=0.3417 G=0.6583
ExAC Global Study-wide 120788 A=0.309170 G=0.690830
ExAC Europe Sub 72846 A=0.31582 G=0.68418
ExAC Asian Sub 25138 A=0.27047 G=0.72953
ExAC American Sub 11552 A=0.22464 G=0.77536
ExAC African Sub 10354 A=0.45132 G=0.54868
ExAC Other Sub 898 A=0.302 G=0.698
The PAGE Study Global Study-wide 78680 A=0.34446 G=0.65554
The PAGE Study AfricanAmerican Sub 32500 A=0.45228 G=0.54772
The PAGE Study Mexican Sub 10810 A=0.24995 G=0.75005
The PAGE Study Asian Sub 8316 A=0.1023 G=0.8977
The PAGE Study PuertoRican Sub 7916 A=0.3469 G=0.6531
The PAGE Study NativeHawaiian Sub 4534 A=0.2532 G=0.7468
The PAGE Study Cuban Sub 4228 A=0.3614 G=0.6386
The PAGE Study Dominican Sub 3828 A=0.3929 G=0.6071
The PAGE Study CentralAmerican Sub 2450 A=0.2522 G=0.7478
The PAGE Study SouthAmerican Sub 1982 A=0.3128 G=0.6872
The PAGE Study NativeAmerican Sub 1260 A=0.3190 G=0.6810
The PAGE Study SouthAsian Sub 856 A=0.332 G=0.668
14KJPN JAPANESE Study-wide 28250 A=0.09395 G=0.90605
8.3KJPN JAPANESE Study-wide 16752 A=0.09187 G=0.90813
1000Genomes_30x Global Study-wide 6404 A=0.3412 G=0.6588
1000Genomes_30x African Sub 1786 A=0.5062 G=0.4938
1000Genomes_30x Europe Sub 1266 A=0.3428 G=0.6572
1000Genomes_30x South Asian Sub 1202 A=0.3735 G=0.6265
1000Genomes_30x East Asian Sub 1170 A=0.0803 G=0.9197
1000Genomes_30x American Sub 980 A=0.310 G=0.690
1000Genomes Global Study-wide 5008 A=0.3357 G=0.6643
1000Genomes African Sub 1322 A=0.5083 G=0.4917
1000Genomes East Asian Sub 1008 A=0.0843 G=0.9157
1000Genomes Europe Sub 1006 A=0.3419 G=0.6581
1000Genomes South Asian Sub 978 A=0.375 G=0.625
1000Genomes American Sub 694 A=0.307 G=0.693
Genetic variation in the Estonian population Estonian Study-wide 4480 A=0.2929 G=0.7071
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 A=0.3324 G=0.6676
UK 10K study - Twins TWIN COHORT Study-wide 3708 A=0.3546 G=0.6454
KOREAN population from KRGDB KOREAN Study-wide 2930 A=0.0922 G=0.9078, T=0.0000
HGDP-CEPH-db Supplement 1 Global Study-wide 2084 A=0.2927 G=0.7073
HGDP-CEPH-db Supplement 1 Est_Asia Sub 470 A=0.100 G=0.900
HGDP-CEPH-db Supplement 1 Central_South_Asia Sub 414 A=0.319 G=0.681
HGDP-CEPH-db Supplement 1 Middle_Est Sub 350 A=0.440 G=0.560
HGDP-CEPH-db Supplement 1 Europe Sub 320 A=0.359 G=0.641
HGDP-CEPH-db Supplement 1 Africa Sub 242 A=0.550 G=0.450
HGDP-CEPH-db Supplement 1 America Sub 216 A=0.093 G=0.907
HGDP-CEPH-db Supplement 1 Oceania Sub 72 A=0.12 G=0.88
HapMap Global Study-wide 1892 A=0.3631 G=0.6369
HapMap American Sub 770 A=0.294 G=0.706
HapMap African Sub 692 A=0.520 G=0.480
HapMap Asian Sub 254 A=0.075 G=0.925
HapMap Europe Sub 176 A=0.466 G=0.534
Korean Genome Project KOREAN Study-wide 1832 A=0.0922 G=0.9078
Genome of the Netherlands Release 5 Genome of the Netherlands Study-wide 998 A=0.329 G=0.671
A Vietnamese Genetic Variation Database Global Study-wide 610 A=0.056 G=0.944
Northern Sweden ACPOP Study-wide 600 A=0.247 G=0.753
Medical Genome Project healthy controls from Spanish population Spanish controls Study-wide 534 A=0.363 G=0.637
SGDP_PRJ Global Study-wide 500 A=0.196 G=0.804
FINRISK Finnish from FINRISK project Study-wide 302 A=0.166 G=0.834
Qatari Global Study-wide 216 A=0.407 G=0.593
Ancient Sardinia genome-wide 1240k capture data generation and analysis Global Study-wide 88 A=0.43 G=0.57
Siberian Global Study-wide 52 A=0.27 G=0.73
The Danish reference pan genome Danish Study-wide 40 A=0.23 G=0.78
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 16 NC_000016.10:g.88646828A>G
GRCh38.p14 chr 16 NC_000016.10:g.88646828A>T
GRCh37.p13 chr 16 NC_000016.9:g.88713236A>G
GRCh37.p13 chr 16 NC_000016.9:g.88713236A>T
CYBA RefSeqGene (LRG_52) NG_007291.1:g.9222T>C
CYBA RefSeqGene (LRG_52) NG_007291.1:g.9222T>A
Gene: CYBA, cytochrome b-245 alpha chain (minus strand)
Molecule type Change Amino acid[Codon] SO Term
CYBA transcript NM_000101.4:c.214T>C Y [TAC] > H [CAC] Coding Sequence Variant
cytochrome b-245 light chain NP_000092.2:p.Tyr72His Y (Tyr) > H (His) Missense Variant
CYBA transcript NM_000101.4:c.214T>A Y [TAC] > N [AAC] Coding Sequence Variant
cytochrome b-245 light chain NP_000092.2:p.Tyr72Asn Y (Tyr) > N (Asn) Missense Variant
CYBA transcript variant X1 XM_011522905.4:c.214T>C Y [TAC] > H [CAC] Coding Sequence Variant
cytochrome b-245 light chain isoform X1 XP_011521207.1:p.Tyr72His Y (Tyr) > H (His) Missense Variant
CYBA transcript variant X1 XM_011522905.4:c.214T>A Y [TAC] > N [AAC] Coding Sequence Variant
cytochrome b-245 light chain isoform X1 XP_011521207.1:p.Tyr72Asn Y (Tyr) > N (Asn) Missense Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: G (allele ID: 17302 )
ClinVar Accession Disease Names Clinical Significance
RCV000002351.4 CYBA POLYMORPHISM Benign
RCV000249071.5 not specified Benign
RCV000736011.1 Very early onset inflammatory bowel disease Likely-Pathogenic
RCV000989646.5 Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative Benign
RCV001723534.2 not provided Benign
RCV001826406.1 Chronic granulomatous disease Benign
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement A= G T
GRCh38.p14 chr 16 NC_000016.10:g.88646828= NC_000016.10:g.88646828A>G NC_000016.10:g.88646828A>T
GRCh37.p13 chr 16 NC_000016.9:g.88713236= NC_000016.9:g.88713236A>G NC_000016.9:g.88713236A>T
CYBA RefSeqGene (LRG_52) NG_007291.1:g.9222= NG_007291.1:g.9222T>C NG_007291.1:g.9222T>A
CYBA transcript NM_000101.4:c.214= NM_000101.4:c.214T>C NM_000101.4:c.214T>A
CYBA transcript NM_000101.3:c.214= NM_000101.3:c.214T>C NM_000101.3:c.214T>A
CYBA transcript variant X1 XM_011522905.4:c.214= XM_011522905.4:c.214T>C XM_011522905.4:c.214T>A
CYBA transcript variant X1 XM_011522905.3:c.214= XM_011522905.3:c.214T>C XM_011522905.3:c.214T>A
CYBA transcript variant X1 XM_011522905.2:c.214= XM_011522905.2:c.214T>C XM_011522905.2:c.214T>A
CYBA transcript variant X1 XM_011522905.1:c.214= XM_011522905.1:c.214T>C XM_011522905.1:c.214T>A
cytochrome b-245 light chain NP_000092.2:p.Tyr72= NP_000092.2:p.Tyr72His NP_000092.2:p.Tyr72Asn
cytochrome b-245 light chain isoform X1 XP_011521207.1:p.Tyr72= XP_011521207.1:p.Tyr72His XP_011521207.1:p.Tyr72Asn
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

209 SubSNP, 29 Frequency, 6 ClinVar submissions
No Submitter Submission ID Date (Build)
1 LEE ss1522617 Oct 13, 2000 (102)
2 WIAF-CSNP ss3173156 Aug 15, 2001 (102)
3 YUSUKE ss3198503 Aug 15, 2001 (103)
4 LEE ss4413910 May 29, 2002 (108)
5 WI_SSAHASNP ss6598678 Feb 20, 2003 (113)
6 SNP500CANCER ss6903734 Mar 31, 2003 (113)
7 BCM_SSAHASNP ss14255553 Dec 05, 2003 (119)
8 CGAP-GAI ss16227053 Feb 27, 2004 (126)
9 CGAP-GAI ss16245512 Feb 27, 2004 (126)
10 CSHL-HAPMAP ss20014987 Feb 27, 2004 (120)
11 SSAHASNP ss21308875 Apr 05, 2004 (121)
12 IMCJ-GDT ss22886987 Apr 05, 2004 (121)
13 PERLEGEN ss23779281 Sep 20, 2004 (123)
14 ABI ss43932524 Mar 10, 2006 (126)
15 APPLERA_GI ss48410351 Mar 10, 2006 (126)
16 ILLUMINA ss65728344 Oct 14, 2006 (127)
17 ILLUMINA ss66684041 Nov 29, 2006 (127)
18 ILLUMINA ss67356879 Nov 29, 2006 (127)
19 ILLUMINA ss67745552 Nov 29, 2006 (127)
20 PERLEGEN ss69355202 May 16, 2007 (127)
21 ILLUMINA ss70814963 May 25, 2008 (130)
22 ILLUMINA ss71395730 May 16, 2007 (127)
23 ILLUMINA ss75585649 Dec 07, 2007 (129)
24 HGSV ss78658647 Dec 07, 2007 (129)
25 ILLUMINA ss79188967 Dec 15, 2007 (130)
26 KRIBB_YJKIM ss83346600 Dec 15, 2007 (130)
27 HGSV ss85800908 Dec 15, 2007 (130)
28 BCMHGSC_JDW ss90496507 Mar 24, 2008 (129)
29 HUMANGENOME_JCVI ss96707974 Feb 05, 2009 (130)
30 BGI ss106491649 Feb 05, 2009 (130)
31 1000GENOMES ss109569667 Jan 24, 2009 (130)
32 1000GENOMES ss113156722 Jan 25, 2009 (130)
33 ILLUMINA-UK ss118365283 Feb 14, 2009 (130)
34 ILLUMINA ss122350717 Dec 01, 2009 (131)
35 ENSEMBL ss136636235 Dec 01, 2009 (131)
36 ENSEMBL ss136881870 Dec 01, 2009 (131)
37 ILLUMINA ss154306504 Dec 01, 2009 (131)
38 GMI ss157721907 Dec 01, 2009 (131)
39 ILLUMINA ss159483301 Dec 01, 2009 (131)
40 SEATTLESEQ ss159733780 Dec 01, 2009 (131)
41 ILLUMINA ss160696733 Dec 01, 2009 (131)
42 COMPLETE_GENOMICS ss168662669 Jul 04, 2010 (132)
43 COMPLETE_GENOMICS ss170632915 Jul 04, 2010 (132)
44 COMPLETE_GENOMICS ss171724169 Jul 04, 2010 (132)
45 ILLUMINA ss171855440 Jul 04, 2010 (132)
46 ILLUMINA ss173775352 Jul 04, 2010 (132)
47 BUSHMAN ss202085667 Jul 04, 2010 (132)
48 BCM-HGSC-SUB ss207689724 Jul 04, 2010 (132)
49 1000GENOMES ss227413149 Jul 14, 2010 (132)
50 1000GENOMES ss237146684 Jul 15, 2010 (132)
51 1000GENOMES ss243463515 Jul 15, 2010 (132)
52 OMICIA ss244239390 Aug 29, 2012 (137)
53 ILLUMINA ss244300718 Jul 04, 2010 (132)
54 OMIM-CURATED-RECORDS ss253284363 Aug 18, 2010 (132)
55 BL ss255881340 May 09, 2011 (134)
56 GMI ss282652630 May 04, 2012 (137)
57 PJP ss291903325 May 09, 2011 (134)
58 NHLBI-ESP ss342436821 May 09, 2011 (134)
59 ILLUMINA ss410934822 Sep 17, 2011 (135)
60 ILLUMINA ss480998602 May 04, 2012 (137)
61 ILLUMINA ss481019302 May 04, 2012 (137)
62 ILLUMINA ss482001230 Sep 08, 2015 (146)
63 ILLUMINA ss485294230 May 04, 2012 (137)
64 1000GENOMES ss491110006 May 04, 2012 (137)
65 EXOME_CHIP ss491513096 May 04, 2012 (137)
66 CLINSEQ_SNP ss491724796 May 04, 2012 (137)
67 ILLUMINA ss537256465 Sep 08, 2015 (146)
68 TISHKOFF ss565104590 Apr 25, 2013 (138)
69 SSMP ss660882773 Apr 25, 2013 (138)
70 ILLUMINA ss778913991 Sep 08, 2015 (146)
71 ILLUMINA ss780722057 Aug 21, 2014 (142)
72 ILLUMINA ss783092992 Sep 08, 2015 (146)
73 ILLUMINA ss783397803 Aug 21, 2014 (142)
74 ILLUMINA ss784050369 Sep 08, 2015 (146)
75 ILLUMINA ss825519485 Apr 01, 2015 (144)
76 ILLUMINA ss832351486 Sep 08, 2015 (146)
77 ILLUMINA ss832994722 Jul 13, 2019 (153)
78 ILLUMINA ss834375371 Sep 08, 2015 (146)
79 JMKIDD_LAB ss974496329 Aug 21, 2014 (142)
80 EVA-GONL ss992817305 Aug 21, 2014 (142)
81 JMKIDD_LAB ss1067564918 Aug 21, 2014 (142)
82 JMKIDD_LAB ss1080861399 Aug 21, 2014 (142)
83 1000GENOMES ss1357505138 Aug 21, 2014 (142)
84 DDI ss1427945169 Apr 01, 2015 (144)
85 EVA_GENOME_DK ss1578046772 Apr 01, 2015 (144)
86 EVA_FINRISK ss1584102106 Apr 01, 2015 (144)
87 EVA_UK10K_ALSPAC ss1635092864 Apr 01, 2015 (144)
88 EVA_UK10K_TWINSUK ss1678086897 Apr 01, 2015 (144)
89 EVA_EXAC ss1692462016 Apr 01, 2015 (144)
90 EVA_DECODE ss1696859007 Apr 01, 2015 (144)
91 EVA_MGP ss1711439958 Apr 01, 2015 (144)
92 EVA_SVP ss1713563154 Apr 01, 2015 (144)
93 ILLUMINA ss1752212126 Sep 08, 2015 (146)
94 ILLUMINA ss1752212127 Sep 08, 2015 (146)
95 HAMMER_LAB ss1808657280 Sep 08, 2015 (146)
96 YSAMUELS ss1849912472 Feb 12, 2016 (147)
97 ILLUMINA ss1917911408 Feb 12, 2016 (147)
98 WEILL_CORNELL_DGM ss1936257083 Feb 12, 2016 (147)
99 ILLUMINA ss1946423479 Feb 12, 2016 (147)
100 ILLUMINA ss1946423480 Feb 12, 2016 (147)
101 ILLUMINA ss1959709458 Feb 12, 2016 (147)
102 ILLUMINA ss1959709459 Feb 12, 2016 (147)
103 GENOMED ss1968331829 Jul 19, 2016 (147)
104 JJLAB ss2028919702 Sep 14, 2016 (149)
105 USC_VALOUEV ss2157359249 Dec 20, 2016 (150)
106 HUMAN_LONGEVITY ss2214710350 Dec 20, 2016 (150)
107 SYSTEMSBIOZJU ss2628949785 Nov 08, 2017 (151)
108 ILLUMINA ss2633361575 Nov 08, 2017 (151)
109 ILLUMINA ss2633361576 Nov 08, 2017 (151)
110 ILLUMINA ss2635067217 Nov 08, 2017 (151)
111 GRF ss2701896078 Nov 08, 2017 (151)
112 ILLUMINA ss2710841305 Nov 08, 2017 (151)
113 GNOMAD ss2742229579 Nov 08, 2017 (151)
114 GNOMAD ss2749620342 Nov 08, 2017 (151)
115 GNOMAD ss2946542090 Nov 08, 2017 (151)
116 AFFY ss2985079498 Nov 08, 2017 (151)
117 AFFY ss2985718187 Nov 08, 2017 (151)
118 SWEGEN ss3015018875 Nov 08, 2017 (151)
119 ILLUMINA ss3021739655 Nov 08, 2017 (151)
120 ILLUMINA ss3021739656 Nov 08, 2017 (151)
121 BIOINF_KMB_FNS_UNIBA ss3028277666 Nov 08, 2017 (151)
122 CSHL ss3351600158 Nov 08, 2017 (151)
123 ILLUMINA ss3625701695 Oct 12, 2018 (152)
124 ILLUMINA ss3627599677 Oct 12, 2018 (152)
125 ILLUMINA ss3627599678 Oct 12, 2018 (152)
126 ILLUMINA ss3631345244 Oct 12, 2018 (152)
127 ILLUMINA ss3633131884 Oct 12, 2018 (152)
128 ILLUMINA ss3633838624 Oct 12, 2018 (152)
129 ILLUMINA ss3634657735 Oct 12, 2018 (152)
130 ILLUMINA ss3634657736 Oct 12, 2018 (152)
131 ILLUMINA ss3635526656 Oct 12, 2018 (152)
132 ILLUMINA ss3636349503 Oct 12, 2018 (152)
133 ILLUMINA ss3637278151 Oct 12, 2018 (152)
134 ILLUMINA ss3638143279 Oct 12, 2018 (152)
135 ILLUMINA ss3639082942 Oct 12, 2018 (152)
136 ILLUMINA ss3639547850 Oct 12, 2018 (152)
137 ILLUMINA ss3640365055 Oct 12, 2018 (152)
138 ILLUMINA ss3640365056 Oct 12, 2018 (152)
139 ILLUMINA ss3643122994 Oct 12, 2018 (152)
140 ILLUMINA ss3644676572 Oct 12, 2018 (152)
141 ILLUMINA ss3644676573 Oct 12, 2018 (152)
142 OMUKHERJEE_ADBS ss3646499483 Oct 12, 2018 (152)
143 URBANLAB ss3650576911 Oct 12, 2018 (152)
144 ILLUMINA ss3652151970 Oct 12, 2018 (152)
145 ILLUMINA ss3652151971 Oct 12, 2018 (152)
146 ILLUMINA ss3653851559 Oct 12, 2018 (152)
147 EGCUT_WGS ss3681997695 Jul 13, 2019 (153)
148 EVA_DECODE ss3699877385 Jul 13, 2019 (153)
149 ILLUMINA ss3725589778 Jul 13, 2019 (153)
150 ACPOP ss3741780088 Jul 13, 2019 (153)
151 ILLUMINA ss3744145718 Jul 13, 2019 (153)
152 ILLUMINA ss3744436344 Jul 13, 2019 (153)
153 ILLUMINA ss3744958106 Jul 13, 2019 (153)
154 ILLUMINA ss3744958107 Jul 13, 2019 (153)
155 EVA ss3754325510 Jul 13, 2019 (153)
156 PAGE_CC ss3771902154 Jul 13, 2019 (153)
157 ILLUMINA ss3772456238 Jul 13, 2019 (153)
158 ILLUMINA ss3772456239 Jul 13, 2019 (153)
159 PACBIO ss3788120947 Jul 13, 2019 (153)
160 PACBIO ss3793091861 Jul 13, 2019 (153)
161 PACBIO ss3797977242 Jul 13, 2019 (153)
162 KHV_HUMAN_GENOMES ss3819597191 Jul 13, 2019 (153)
163 EVA ss3825048765 Apr 27, 2020 (154)
164 EVA ss3825886184 Apr 27, 2020 (154)
165 EVA ss3834725918 Apr 27, 2020 (154)
166 EVA ss3840970522 Apr 27, 2020 (154)
167 EVA ss3846464205 Apr 27, 2020 (154)
168 HGDP ss3847555842 Apr 27, 2020 (154)
169 SGDP_PRJ ss3885102863 Apr 27, 2020 (154)
170 KRGDB ss3934660041 Apr 27, 2020 (154)
171 KOGIC ss3978192084 Apr 27, 2020 (154)
172 FSA-LAB ss3984101357 Apr 26, 2021 (155)
173 EVA ss3984718026 Apr 26, 2021 (155)
174 EVA ss3984718027 Apr 26, 2021 (155)
175 EVA ss3985775846 Apr 26, 2021 (155)
176 EVA ss3986071836 Apr 26, 2021 (155)
177 EVA ss3986701205 Apr 26, 2021 (155)
178 TOPMED ss5026172813 Apr 26, 2021 (155)
179 TOMMO_GENOMICS ss5220996852 Apr 26, 2021 (155)
180 EVA ss5236936731 Apr 26, 2021 (155)
181 EVA ss5237236166 Apr 26, 2021 (155)
182 EVA ss5237667255 Oct 16, 2022 (156)
183 1000G_HIGH_COVERAGE ss5302056234 Oct 16, 2022 (156)
184 TRAN_CS_UWATERLOO ss5314445718 Oct 16, 2022 (156)
185 EVA ss5315864808 Oct 16, 2022 (156)
186 EVA ss5425731812 Oct 16, 2022 (156)
187 HUGCELL_USP ss5495285566 Oct 16, 2022 (156)
188 EVA ss5511700333 Oct 16, 2022 (156)
189 1000G_HIGH_COVERAGE ss5605258226 Oct 16, 2022 (156)
190 EVA ss5623968870 Oct 16, 2022 (156)
191 EVA ss5624065894 Oct 16, 2022 (156)
192 SANFORD_IMAGENETICS ss5624389268 Oct 16, 2022 (156)
193 SANFORD_IMAGENETICS ss5659517623 Oct 16, 2022 (156)
194 TOMMO_GENOMICS ss5776423249 Oct 16, 2022 (156)
195 EVA ss5799967458 Oct 16, 2022 (156)
196 EVA ss5800203702 Oct 16, 2022 (156)
197 YY_MCH ss5816240512 Oct 16, 2022 (156)
198 EVA ss5846839897 Oct 16, 2022 (156)
199 EVA ss5847469070 Oct 16, 2022 (156)
200 EVA ss5847782850 Oct 16, 2022 (156)
201 EVA ss5848433735 Oct 16, 2022 (156)
202 EVA ss5851697021 Oct 16, 2022 (156)
203 EVA ss5900348045 Oct 16, 2022 (156)
204 EVA ss5936273609 Oct 16, 2022 (156)
205 EVA ss5936565211 Oct 16, 2022 (156)
206 EVA ss5950933964 Oct 16, 2022 (156)
207 EVA ss5979496068 Oct 16, 2022 (156)
208 EVA ss5980941509 Oct 16, 2022 (156)
209 EVA ss5981297432 Oct 16, 2022 (156)
210 1000Genomes NC_000016.9 - 88713236 Oct 12, 2018 (152)
211 1000Genomes_30x NC_000016.10 - 88646828 Oct 16, 2022 (156)
212 The Avon Longitudinal Study of Parents and Children NC_000016.9 - 88713236 Oct 12, 2018 (152)
213 Genetic variation in the Estonian population NC_000016.9 - 88713236 Oct 12, 2018 (152)
214 ExAC NC_000016.9 - 88713236 Oct 12, 2018 (152)
215 FINRISK NC_000016.9 - 88713236 Apr 27, 2020 (154)
216 The Danish reference pan genome NC_000016.9 - 88713236 Apr 27, 2020 (154)
217 gnomAD - Genomes NC_000016.10 - 88646828 Apr 26, 2021 (155)
218 gnomAD - Exomes NC_000016.9 - 88713236 Jul 13, 2019 (153)
219 Genome of the Netherlands Release 5 NC_000016.9 - 88713236 Apr 27, 2020 (154)
220 HGDP-CEPH-db Supplement 1 NC_000016.8 - 87240737 Apr 27, 2020 (154)
221 HapMap NC_000016.10 - 88646828 Apr 27, 2020 (154)
222 KOREAN population from KRGDB NC_000016.9 - 88713236 Apr 27, 2020 (154)
223 Korean Genome Project NC_000016.10 - 88646828 Apr 27, 2020 (154)
224 Medical Genome Project healthy controls from Spanish population NC_000016.9 - 88713236 Apr 27, 2020 (154)
225 Northern Sweden NC_000016.9 - 88713236 Jul 13, 2019 (153)
226 The PAGE Study NC_000016.10 - 88646828 Jul 13, 2019 (153)
227 Ancient Sardinia genome-wide 1240k capture data generation and analysis NC_000016.9 - 88713236 Apr 26, 2021 (155)
228 CNV burdens in cranial meningiomas

Submission ignored due to conflicting rows:
Row 267564 (NC_000016.9:88713235:A:G 720/790)
Row 267565 (NC_000016.9:88713235:A:G 719/788)

- Apr 26, 2021 (155)
229 CNV burdens in cranial meningiomas

Submission ignored due to conflicting rows:
Row 267564 (NC_000016.9:88713235:A:G 720/790)
Row 267565 (NC_000016.9:88713235:A:G 719/788)

- Apr 26, 2021 (155)
230 Qatari NC_000016.9 - 88713236 Apr 27, 2020 (154)
231 SGDP_PRJ NC_000016.9 - 88713236 Apr 27, 2020 (154)
232 Siberian NC_000016.9 - 88713236 Apr 27, 2020 (154)
233 8.3KJPN NC_000016.9 - 88713236 Apr 26, 2021 (155)
234 14KJPN NC_000016.10 - 88646828 Oct 16, 2022 (156)
235 TopMed NC_000016.10 - 88646828 Apr 26, 2021 (155)
236 UK 10K study - Twins NC_000016.9 - 88713236 Oct 12, 2018 (152)
237 A Vietnamese Genetic Variation Database NC_000016.9 - 88713236 Jul 13, 2019 (153)
238 ALFA NC_000016.10 - 88646828 Apr 26, 2021 (155)
239 ClinVar RCV000002351.4 Jul 13, 2019 (153)
240 ClinVar RCV000249071.5 Oct 16, 2022 (156)
241 ClinVar RCV000736011.1 Jul 13, 2019 (153)
242 ClinVar RCV000989646.5 Oct 16, 2022 (156)
243 ClinVar RCV001723534.2 Oct 16, 2022 (156)
244 ClinVar RCV001826406.1 Oct 16, 2022 (156)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs1130413 Jan 04, 2002 (102)
rs2228471 Jan 04, 2002 (102)
rs2242272 Mar 26, 2002 (103)
rs3189211 Oct 08, 2002 (108)
rs4782392 Apr 07, 2003 (113)
rs11266997 Mar 10, 2006 (126)
rs59455247 May 25, 2008 (130)
rs386594564 Aug 06, 2014 (136)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
233734, ss78658647, ss85800908, ss90496507, ss109569667, ss113156722, ss118365283, ss160696733, ss168662669, ss170632915, ss171724169, ss202085667, ss207689724, ss244300718, ss255881340, ss282652630, ss291903325, ss480998602, ss491724796, ss825519485, ss1696859007, ss1713563154, ss2635067217, ss3639082942, ss3639547850, ss3643122994, ss3847555842 NC_000016.8:87240736:A:G NC_000016.10:88646827:A:G (self)
70704913, 39227132, 27735943, 2880579, 98567, 4253664, 11518830, 17486697, 41837435, 555718, 15064953, 1001773, 18299005, 37119843, 9875603, 78966159, 39227132, 8691999, ss227413149, ss237146684, ss243463515, ss342436821, ss481019302, ss482001230, ss485294230, ss491110006, ss491513096, ss537256465, ss565104590, ss660882773, ss778913991, ss780722057, ss783092992, ss783397803, ss784050369, ss832351486, ss832994722, ss834375371, ss974496329, ss992817305, ss1067564918, ss1080861399, ss1357505138, ss1427945169, ss1578046772, ss1584102106, ss1635092864, ss1678086897, ss1692462016, ss1711439958, ss1752212126, ss1752212127, ss1808657280, ss1849912472, ss1917911408, ss1936257083, ss1946423479, ss1946423480, ss1959709458, ss1959709459, ss1968331829, ss2028919702, ss2157359249, ss2628949785, ss2633361575, ss2633361576, ss2701896078, ss2710841305, ss2742229579, ss2749620342, ss2946542090, ss2985079498, ss2985718187, ss3015018875, ss3021739655, ss3021739656, ss3351600158, ss3625701695, ss3627599677, ss3627599678, ss3631345244, ss3633131884, ss3633838624, ss3634657735, ss3634657736, ss3635526656, ss3636349503, ss3637278151, ss3638143279, ss3640365055, ss3640365056, ss3644676572, ss3644676573, ss3646499483, ss3652151970, ss3652151971, ss3653851559, ss3681997695, ss3741780088, ss3744145718, ss3744436344, ss3744958106, ss3744958107, ss3754325510, ss3772456238, ss3772456239, ss3788120947, ss3793091861, ss3797977242, ss3825048765, ss3825886184, ss3834725918, ss3840970522, ss3885102863, ss3934660041, ss3984101357, ss3984718026, ss3984718027, ss3985775846, ss3986071836, ss3986701205, ss5220996852, ss5315864808, ss5425731812, ss5511700333, ss5623968870, ss5624065894, ss5624389268, ss5659517623, ss5799967458, ss5800203702, ss5846839897, ss5847469070, ss5847782850, ss5848433735, ss5936273609, ss5936565211, ss5950933964, ss5979496068, ss5980941509, ss5981297432 NC_000016.9:88713235:A:G NC_000016.10:88646827:A:G (self)
RCV000002351.4, RCV000249071.5, RCV000736011.1, RCV000989646.5, RCV001723534.2, RCV001826406.1, 92784161, 498597463, 1442286, 34570085, 1123623, 110260353, 241718474, 7828618530, ss244239390, ss253284363, ss2214710350, ss3028277666, ss3650576911, ss3699877385, ss3725589778, ss3771902154, ss3819597191, ss3846464205, ss3978192084, ss5026172813, ss5236936731, ss5237236166, ss5237667255, ss5302056234, ss5314445718, ss5495285566, ss5605258226, ss5776423249, ss5816240512, ss5851697021, ss5900348045 NC_000016.10:88646827:A:G NC_000016.10:88646827:A:G (self)
ss14255553, ss20014987, ss21308875 NT_010542.14:271035:A:G NC_000016.10:88646827:A:G (self)
ss1522617, ss3173156, ss3198503, ss4413910, ss6598678, ss6903734, ss16227053, ss16245512, ss22886987, ss23779281, ss43932524, ss48410351, ss65728344, ss66684041, ss67356879, ss67745552, ss69355202, ss70814963, ss71395730, ss75585649, ss79188967, ss83346600, ss96707974, ss106491649, ss122350717, ss136636235, ss136881870, ss154306504, ss157721907, ss159483301, ss159733780, ss171855440, ss173775352, ss410934822 NT_010542.15:273852:A:G NC_000016.10:88646827:A:G (self)
41837435, ss3934660041 NC_000016.9:88713235:A:T NC_000016.10:88646827:A:T (self)
7828618530 NC_000016.10:88646827:A:T NC_000016.10:88646827:A:T (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

70 citations for rs4673
PMID Title Author Year Journal
3368442 Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b. Parkos CA et al. 1988 Proceedings of the National Academy of Sciences of the United States of America
9445163 Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Inoue N et al. 1998 Circulation
10440830 Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function. Li A et al. 1999 American journal of medical genetics
16330681 NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Wojnowski L et al. 2005 Circulation
16595073 Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: potential breast cancer risk alleles and their distribution across human populations. Savas S et al. 2006 Human genomics
16608528 Genetic polymorphisms and susceptibility to lung disease. Lee PL et al. 2006 Journal of negative results in biomedicine
17825092 Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography. Nemoto M et al. 2007 Cardiovascular diabetology
18182569 Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group. Davies SM et al. 2008 Blood
19379518 Development of a fingerprinting panel using medically relevant polymorphisms. Cross DS et al. 2009 BMC medical genomics
19388116 Three common polymorphisms in the CYBA gene form a haplotype associated with decreased ROS generation. Bedard K et al. 2009 Human mutation
19423521 Genetic polymorphisms in nitric oxide synthase genes modify the relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma. Han X et al. 2009 Cancer epidemiology, biomarkers & prevention
19448608 Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21. Rossi D et al. 2009 Leukemia
20100625 Association of p22phox gene C242T polymorphism with coronary artery disease: a meta-analysis. Fang S et al. 2010 Thrombosis research
20565774 Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project. Cross DS et al. 2010 BMC genetics
20581851 Exploring epistatic relationships of NO biosynthesis pathway genes in susceptibility to CHD. Tu YC et al. 2010 Acta pharmacologica Sinica
21048526 Doxorubicin pathways: pharmacodynamics and adverse effects. Thorn CF et al. 2011 Pharmacogenetics and genomics
21902598 Cognitive function in prepubertal children with obstructive sleep apnea: a modifying role for NADPH oxidase p22 subunit gene polymorphisms? Gozal D et al. 2012 Antioxidants & redox signaling
21962117 Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus. Vieira SM et al. 2011 BMC medical genetics
21963893 Polymorphisms of genes in nitric oxide-forming pathway associated with ischemic stroke in Chinese Han population. Yan JT et al. 2011 Acta pharmacologica Sinica
22024213 A novel gene-environment interaction involved in endometriosis. McCarty CA et al. 2012 International journal of gynaecology and obstetrics
22199011 Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Murabito JM et al. 2012 Circulation. Cardiovascular genetics
22410402 Association between rs4673 (C/T) and rs13306294 (A/G) haplotypes of NAD(P)H oxidase p22phox gene and severity of stenosis in coronary arteries. Najafi M et al. 2012 Gene
22470385 CYBA Gene Polymorphisms and Adverse Outcomes in Acute Kidney Injury: A Prospective Cohort Study. Perianayagam MC et al. 2011 Nephron extra
22879966 Systematic testing of literature reported genetic variation associated with coronary restenosis: results of the GENDER Study. Verschuren JJ et al. 2012 PloS one
22919264 No difference in genotype frequencies of polymorphisms of the nitric oxide pathway between Caucasian normal and high tension glaucoma patients. Weiss J et al. 2012 Molecular vision
23560644 Polymorphisms in genes involved in the free-radical process in patients with sudden sensorineural hearing loss and Ménière's disease. Teranishi M et al. 2013 Free radical research
23725037 Polymorphism in the HMOX1 gene is associated with high levels of fetal hemoglobin in Brazilian patients with sickle cell anemia. Gil GP et al. 2013 Hemoglobin
23821607 Evolutionary dynamics of the human NADPH oxidase genes CYBB, CYBA, NCF2, and NCF4: functional implications. Tarazona-Santos E et al. 2013 Molecular biology and evolution
24156725 Association of the C242T polymorphism in the NAD(P)H oxidase P22 phox gene with type 2 diabetes mellitus risk: a meta-analysis. Sun Q et al. 2014 Current medical research and opinion
24562334 Genetics of oxidative stress in obesity. Rupérez AI et al. 2014 International journal of molecular sciences
24895604 Antioxidant defense enzyme genes and asthma susceptibility: gender-specific effects and heterogeneity in gene-gene interactions between pathogenetic variants of the disease. Polonikov AV et al. 2014 BioMed research international
25168315 Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Vulsteke C et al. 2014 Breast cancer research and treatment
25741868 Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Richards S et al. 2015 Genetics in medicine
26627480 Genetic predisposition to acute kidney injury--a systematic review. Vilander LM et al. 2015 BMC nephrology
26648684 Update on genetics and diabetic retinopathy. Hampton BM et al. 2015 Clinical ophthalmology (Auckland, N.Z.)
26660092 Association between NAD(P)H oxidase p22phox gene variants and acute myocardial infarction in a Han Chinese population. Xu H et al. 2016 Herz
26862503 Cutting-edge technologies for diagnosis and monitoring of snoring in children. Vlastos I et al. 2016 World journal of clinical pediatrics
27277665 Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population. Zholdybayeva EV et al. 2016 Human genomics
27314008 The CYBA Gene (⁎)49A>G Polymorphism (rs7195830) Is Associated with Hypertension in Patients with Coronary Artery Disease. Nowak T et al. 2016 BioMed research international
27618304 The Value of Online Algorithms to Predict T-Cell Ligands Created by Genetic Variants. van der Lee DI et al. 2016 PloS one
27901128 Heterozygote Advantage of the rs3794624 Polymorphism in CYBA for Resistance to Tuberculosis in Two Chinese Populations. Liu Q et al. 2016 Scientific reports
27926811 p22phox C242T gene polymorphism and overt diabetic nephropathy: a meta-analysis of 1,452 participants. Li YY et al. 2017 The Korean journal of internal medicine
28232737 Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis. Leong SL et al. 2017 Scientific reports
28233034 Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2α) polymorphism lowers hemoglobin concentration in Tibetan highlanders. Tashi T et al. 2017 Journal of molecular medicine (Berlin, Germany)
28233473 Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome. Sun Y et al. 2017 Journal of cellular and molecular medicine
28356848 Genetic Variants of Cytochrome b-245, Alpha Polypeptide Gene and Premature Acute Myocardial Infarction Risk in an Iranian Population. Amin F et al. 2015 Journal of medical biochemistry
28474233 Association analysis of rs1049255 and rs4673 transitions in p22phox gene with coronary artery disease: A case-control study and a computational analysis. Mazaheri M et al. 2017 Irish journal of medical science
28485375 Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy. Megías-Vericat JE et al. 2018 The pharmacogenomics journal
28529598 Biological interaction of cigarette smoking on the association between genetic polymorphisms involved in inflammation and the risk of lung cancer: A case-control study in Japan. Yamamoto Y et al. 2017 Oncology letters
28679691 Metastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events. Meißner T et al. 2017 Cold Spring Harbor molecular case studies
29132304 The three CYBA variants (rs4673, rs1049254 and rs1049255) are benign: new evidence from a patient with CGD. Sun J et al. 2017 BMC medical genetics
29342889 A Case-Control Study of the Genetic Variability in Reactive Oxygen Species-Metabolizing Enzymes in Melanoma Risk. Yuan TA et al. 2018 International journal of molecular sciences
29924645 Association of Polymorphisms in CYBA, SOD1, and CAT Genes with Type 1 Diabetes and Diabetic Peripheral Neuropathy in Children and Adolescents. Snahnicanova Z et al. 2018 Genetic testing and molecular biomarkers
30654669 Association of single nucleotide polymorphisms in the CYBA gene with coal workers' pneumoconiosis in the Han Chinese population. Yuan B et al. 2018 Inhalation toxicology
31231424 Genetic and Epigenetic Studies in Diabetic Kidney Disease. Gu HF et al. 2019 Frontiers in genetics
31969899 Oxidative Stress-Related Gene Polymorphisms Are Associated With Hepatitis B Virus-Induced Liver Disease in the Northern Chinese Han Population. Ma N et al. 2019 Frontiers in genetics
32406080 The association between CYBA gene C242T variant and risk of metabolic syndrome. Pourgholi L et al. 2020 European journal of clinical investigation
32423015 NADPH Oxidase Gene Polymorphism is Associated with Mortality and Cardiovascular Events in 7-Year Follow-Up. Racis M et al. 2020 Journal of clinical medicine
32991532 Influence of Oxidative Stress-Related Genes on Susceptibility to Fibromyalgia. Rus A et al. 2021 Nursing research
33145364 Association of NCF2, NCF4, and CYBA Gene Polymorphisms with Rheumatoid Arthritis in a Chinese Population. Zhang TP et al. 2020 Journal of immunology research
33596565 Anthracycline-Induced Cardiotoxicity: The Role of Endothelial Dysfunction. Grakova EV et al. 2021 Cardiology
33652340 Association of Aquaporin-3, Aquaporin-7, NOS3 and CYBA polymorphisms with hypertensive disorders in women. da Silva IV et al. 2021 Pregnancy hypertension
34150864 Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis. Yang X et al. 2021 Frontiers in cardiovascular medicine
34444074 Interaction of Smoking and Lead Exposure among Carriers of Genetic Variants Associated with a Higher Level of Oxidative Stress Indicators. Ho KJ et al. 2021 International journal of environmental research and public health
34783301 Anthracycline-induced cardiotoxicity in women without cardiovascular diseases: molecular and genetic predictors. Kopeva KV et al. 2022 Acta cardiologica
34970365 Cytochrome b-245 Alpha Chain Gene Variants and Arterial Function in Indonesian Short Stature Children. Maharani N et al. 2021 Cardiology research
35073438 Impact of CYBA genotypes on severity and progression of multiple sclerosis. Törnell A et al. 2022 European journal of neurology
35165463 [Gene polymorphisms of cytochrome B-245 alpha chain (CYBA) and cholesteryl ester transfer protein (CETP) and susceptibility to generalized aggressive periodontitis]. Zhu XL et al. 2022 Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
35192760 RS4673 and pon1 level in blood plasma - new prospects in prediction and early diagnostics of anthracycline-mediated cardiotoxicity. Gvaldin DY et al. 2022 Klinicheskaia laboratornaia diagnostika
35335935 Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives. Pinto-Merino Á et al. 2022 Pharmaceutics
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post820+afb47a3d